Presenters
Clinical Reader in Diabetes and Cardiovascular Disease
Prof. Janaka Karalliedde, MBBS, FRCP, FHEA, PhD
Course Details
The aim of this webinar is to provide updates on how Linagliptin has brought improvements in diabetes care over the last 10 years. It will discuss the clinical trials of linagliptin – its efficacy, cardiovascular and renal safety and convenience across a broad range of T2D patients, and how it supports the simplicity of its use for these patients.
CPD Points: 1 Point
PRC Program No: PROG-2022-23034
Delivering 10 years of Improvements in Diabetes Care Course Outline
- How did Linagliptin improve Type 2 Diabetes care in the last 10 years?
- CARMELINA and CAROLINA: an Extensive Dataset from a Unique CVOT program
- Efficacy of Linagliptin in T2D patients
- Can a broad range of T2D patients benefit from the Simplicity of Linagliptin
- Course Evaluation